Drug Combination Details
| General Information of the Combination (ID: C06586) | |||||
|---|---|---|---|---|---|
| Name | Ginsenoside NP Info | + | Cyclophosphamide Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Lung cancer
[ICD-11: 2C25]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vivo Model | C57BL/6 mice were inoculated by subcutaneous injection in the right front axilla with 1 * 106 Lewis cells. | |||||
| Experimental
Result(s) |
Combination of Ginsenoside H dripping pills and cyclophosphamide improve paraneoplastic syndrome and inhibit postoperative recurrence via the reversion of Th1/Th2 shift. | |||||
